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linical characteristics and risk factors associated with melioi-
osis in Bintulu Hospital, Sarawak, Malaysia
. Ahmad ∗, A.A. Mohd Arshad, J.S. Wong, C. Goh, A. Mohan, A.
yub
Hospital Bintulu, Bintulu, Sarawak, Malaysia
Background: Melioidosis is an infection with gram negative
acterium Burkholderia pseudomallei and is an important public
ealth problem causing community acquired sepsis in South East
sia and north Australia. The calculated annual incidence ofmelioi-
osis in Malaysia varies from around 6.0 per 100,000 per year to
6.35per100,000populationper year for adult populationdepend-
ng on region.
Methods: From October 2007 to January 2012, 416 patients
ere positive for melioidosis based on serology and 46 patients
ad microbiologically documented melioidosis. We undertook ret-
ospective analysis of 46 cases with culture conﬁrmed cases.
Results:Themeanageof patientwas36years old,withpredom-
nantly male (60.9%) and Iban ethnic group involvement (41.3%).
ajority of patients were involved in farming, forestry and ﬁsh-
ng (52.2%), followed by children and teenagers who were involved
p to 17.4%. Majority did not have medical co morbidity (63.0%)
nlike other reports where diabetes mellitus is one of the recog-
ized risk factor. Almost half of the patients (47.8%) were admitted
o Intensive Care Unit (ICU) due to respiratory failure or septic
hock. Pneumonia was the commonest presentation (69.9%) and
ccounted for 95.5% ICU admissions. Most patients received cef-
azidime (52.2%), followed by meropenem (32.6%) and imipenem
2.2%). Only 13% did not received suggested antimicrobial treat-
ent due to low suspicion. The overall mortality rate was 47.8%,
ut the rate was as high as 60.6% in pulmonary involvement. Based
n in vitro sensitivity testing using disc diffusion method, 42.5%
linical isolates were resistant to meropenem. In vivo, we observed
hat 45.5% of patients whom received meropenem died.
Conclusion: Majority of our patients were younger, with
ore than half having no medical co morbidity. Patients mainly
resented with lung involvement and bacteraemic. Pulmonary
nvolvement carried a higher mortality rate despite appropriate
reatment. In vitro resistance towardsmeropenemneeds to be con-
rmed by minimum inhibitory method as it has colossal impact
owards current clinical practice.
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Actual problems of the prophylaxis of pertussis in Russian Fed-
eration
V. Aleshkin ∗, O. Tsvircun, O. Borisova, A. Basov, N. Gadua
G.N. Gabrichevsky Institute of Epidemiology and Microbiology,
Moscow, Russian Federation
Background:Theurgencyof thepertussis situationnowadays is
causedby the remaining lethality and involving inepidemicprocess
of primary school age children.
Methods: Epidemiological, serological, microbiological,
molecular-genetic.
Results: The occurrence rate of pertussis in the RF between
2008-2011 stabilized at 2.5-3.8 per 100 000 people, including 1-
4 lethal cases, mainly among children under age one. The severity
of the illness depends on anatomic and physiological features of
an organism, immunity of the individual, accompanying infectious
diseases, as well as the agent’s biological features.
The distribution of the disease in Russia’s 66 regions is sporadic.
9 regions show5-10 cases per 100000; in another 8 regions the rate
ispracticallynil. In2011 infection sourceswereestablished in11,6%
of cases. It is presumed that the morbidity rate is underestimated.
Pertussis is registered in both non-vaccinated and vaccinated
persons. The highest occurrence rate of vaccinated patients occurs
in the age category of 6-10,which suggests a reduction of immunity
to pertussis among children of this age, and leads us to question
the appropriateness of the second revaccination at the age of 6.
According to the WHO, many countries revaccinate a second and
third time.
Most of the modern-day circulating strains, as compared to
the strains included in the current DPT vaccine, have a number
of changes in their proteins, which determine the pathogenic and
immunogenic features of the microbe. To construct a new pertus-
sis vaccine, including an acellular vaccine, 3 candidate strains have
been selected (together with I.I. Mechnikov’s Research Institute for
Vaccines and Serums of the Russian Academy of Medical Sciences).
Being aware that laboratory diagnostics for pertussis require
signiﬁcant improvement, a rapid diagnosistic method based
on loop-mediated isothermal ampliﬁcation has been developed
(LAMP). The LAMP does not require expensive equipment and the
accuracy rate is 72.7% - 100%, depending on the terms and stage of
the disease.
Conclusion: It is necessary to develop a set of measures aimed
to improve speciﬁc prophylaxis of pertussis, and the inclusion in
healthcare practice of highly effective molecular - genetic methods
of lab diagnostics.
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